MET

MetLife
D

MET

Arincen73/100B

If you had invested in MetLife ago, it would be worth $2,966 today, against $4,096 in SPY and $6,368 in QQQ.

ArincenArincen ScoreBeta

73/100

Six parts of the company, five checks each, from its own reported figures. A part scores the checks it passes out of 10; the score is their average out of 100.

Profitability4

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Cash10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Valuation10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Growth6

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Financial strength6

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Shareholders8

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Figures to FY2025; the price as of today.

MetLife key facts

Style
Value stock · 7.6/10Growth 3.8 · Value 7.6 · Dividend 6.5
Day range
101.560 – 103.990
52-week range
67.330 – 106.720
Market capitalization
63.99B USD
P/E
13.19
PEG ratio
0.36
EPS
7.72
Div Yield
2.33%
EPS growth forecast (FY2026)
+15.0%
Volume
30,527
Beta
0.77
ESG score
57.5/100Environment 59 · Social 59 · Governance 54
Sector
Financial Services
Industry
Insurance - Life
CEO
Michel Abbas Khalaf
Employees
46K
IPO date
5 Apr 2000

MetLife earnings

Next earnings · Q4 FY2026
EPS estimate
2.62 USD
Revenue estimate
20.68B USD
Last quarter · Q3 FY2026
EPS2.78Beat +0.4%Revenue20.52BBeat +3.4%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20272.86——+3.05%20.86B——+1.64%
Q2 FY20272.81——+15.57%20.48B——+7.35%
Q1 FY20272.57——+6.09%20.43B——+3.81%
Q4 FY20262.62——+1.55%20.68B——-13.14%
Q3 FY20262.772.78+0.36%+18.80%19.86B20.52B+3.36%+21.57%
Q2 FY20262.302.43+5.65%+20.30%19.67B19.08B-3.00%+10.01%
Q1 FY20262.272.42+6.61%+23.47%19.49B19.68B+1.00%+7.65%
Q4 FY20252.342.58+10.26%+24.04%27.22B23.81B-12.51%+29.59%
Q3 FY20252.312.34+1.30%+20.00%18.64B16.88B-9.44%-8.45%
Q2 FY20252.152.02-6.05%-11.40%18.53B17.34B-6.45%-2.71%

Analysts' estimates for FY2026 over the last 7 days:EPS Revenue How the estimates moved

MetLife analyst forecast

12-month price target
108.63 USD
+6.68%

Analysts' 1-year price targets range from 103.00 to 112.00, with an average of 108.63.

Past year
1-year forecast
Strong sellStrong buy
Strong buy
12 ratings
Buy
11
Hold
1
Sell
0

12-month price target

Highest target112.00
Average target108.63
Lowest target103.00
Current price101.83

MetLife valuation

Price to earnings ratio (TTM)
13.19
Forward P/E (FY2026)
9.95
Price to sales (TTM)
0.78
Price to book
2.88
EV / EBITDA (TTM)
-34.60

Capital structure

Market capitalization
63.99B USD
+
Total debt
21.68B USD
−
Cash and short-term investments
354.48B USD
=
Enterprise value
-268.81B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)8.23————
FY2027 (est.)9.128.23———
FY2026 (est.)9.959.12———
Now (TTM)13.199.220.782.88-34.60
FY202516.457.710.681.857.82
FY202413.699.430.812.067.47
FY202336.348.070.741.6812.38
FY202211.409.900.831.896.79
FY20218.128.990.810.764.83

MetLife against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Aflac, Prudential Financial, Globe Life, Unum Group, Voya Financial, and Primerica, the US Insurance - Life companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Below its median13.2
    6.540.5
  • Gross marginHighest in 5 years36.4%
    25.5%36.4%
    Against its peers: 5 of 7Peers' median 38.6%
  • Operating marginBelow its median6.0%
    3.2%13.4%
    Against its peers: 6 of 7Peers' median 16.0%
  • Net marginBelow its median4.4%
    2.3%10.8%
    Against its peers: 7 of 7Peers' median 14.0%
  • Return on equityAt its median11.9%
    5.3%17.7%
    Against its peers: 5 of 7Peers' median 12.8%
  • Free cash flow marginHighest in 5 years23.5%
    16.7%23.5%
    Against its peers: 2 of 7Peers' median 15.9%
  • Revenue growthHighest in 5 years10.2%
    -6.7%10.2%
    Against its peers: 1 of 7Peers' median -2.4%
  • EPS growthBelow its median-19.2%
    -71.3%228.2%
    Against its peers: 5 of 7Peers' median 10.1%
  • Debt to EBITDAAbove its median3.12×
    1.72×4.80×
    Against its peers: 5 of 7Peers' median 2.44×
  • Current ratioBelow its median0.65
    0.551.47
    Against its peers: 5 of 6Peers' median 9.66

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

MetLife growth and profitability

Revenue (TTM)
82.29B USD
Net income (TTM)
5.13B USD
Gross margin
29.23%
Operating margin
8.44%
Net margin
6.23%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202577.08B+10.22%3.38B-23.66%36.36%6.05%4.38%6.48B-12.18%
FY202469.94B+3.29%4.43B+180.48%27.17%8.04%6.33%7.37B+87.85%
FY202367.71B-0.38%1.58B-70.14%25.53%3.19%2.33%3.93B-50.78%
FY202267.97B+7.26%5.28B-22.92%27.86%9.36%7.77%7.98B-21.29%
FY202163.37B-6.66%6.86B+26.78%26.57%13.44%10.82%10.13B+19.78%

MetLife revenue breakdown

By product

FY2025
Prepaid legal plans and administrative-only contracts: 26.1%Vision fee for service arrangements: 23.0%Other revenue from service contracts from customers: 17.7%Fee-based investment management services: 15.1%Administrative Service: 12.1%Distribution Service: 5.8%26.1%Prepaid legal plans and administrative-only contracts23.0%Vision fee for service arrangements17.7%Other revenue from service contracts from customers15.1%Fee-based investment management services12.1%Administrative Service5.8%Distribution Service
SegmentRevenueShare of revenueChange on the year
Prepaid legal plans and administrative-only contracts637.00M26.1%+11.4%
Vision fee for service arrangements561.00M23.0%+4.7%
Other revenue from service contracts from customers432.00M17.7%+35.4%
Fee-based investment management services369.00M15.1%-6.3%
Administrative Service295.00M12.1%+8.1%
Distribution Service142.00M5.8%-6.0%

By region

FY2025
Asia: 56.4%Latin America: 27.3%Europe, Middle East And Africa: 16.4%56.4%Asia27.3%Latin America16.4%Europe, Middle East And Africa
RegionRevenueShare of revenueChange on the year
Asia238.00M56.4%-97.8%
Latin America115.00M27.3%-98.4%
Europe, Middle East And Africa69.00M16.4%—

How MetLife makes its money

Revenue77.08B 100.0%
Cost of revenue49.06B 63.6%
Gross profit28.02B 36.4%
Other operating expenses23.36B 30.3%
Operating income4.66B 6.0%
Tax1.26B 1.6%
Other expense24.00M 0.0%
Net income3.38B 4.4%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

MetLife dividends

Annual dividend
2.37 USD
Dividend yield (indicated)
2.33%
Payout ratio
30.38%
Years of dividend growth
13
Frequency
Quarterly
Next payment
0.59 USD
Last ex-dividend date
3 Nov 2026
Next payment date
8 Dec 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share2.252.162.061.981.901.821.741.661.471.40

MetLife financial health

Cash and short-term investments
354.48B USD
Total debt
21.68B USD
Net cash
332.81B USD
Free cash flow (TTM)
15.00B USD
Current ratio
2.29
Debt to equity
0.98
Piotroski score
8 / 9
Altman Z-score
0.68

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY2025125.34B20.18B18.11B
FY2024108.78B18.72B15.12B
FY2023316.83B18.83B14.26B
FY2022313.32B17.98B11.37B
FY2021367.50B17.43B12.83B

MetLife ownership

Institutions
75.02%
Institutional holders
1,517 (+71)
Free float
83.66%

Who owns the shares

Institutions 75.0% Others 25.0%
As of 30 Jun 2026

Shares free to trade

Free float 525.77M shares ·83.7% Closely held 102.67M shares ·16.3%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q3 2026001.36K18.48K
Q2 20260029.43K0.00
Q1 202600344.34K122.49K
Q4 20250018.93K4.42K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025664.96M664.96M-6.49%
FY2024689.21M711.10M-6.73%
FY2023762.43M762.43M-5.74%
FY2022779.10M808.90M-6.96%
FY2021825.54M869.40M-4.80%

Source: Financial Modeling Prep

Related Instruments

Title: MetLife

Sector: Financial Services
Industry: Insurance - Life
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.

Common questions about MetLife stock